It's a pretty tricky assay, and not always conclusive. We can genotype TREX1 if they'd like that done.
Labels
Aicardi-Goutières Syndrome
(2)
Allergen-Specific IgE-RAST-CAP
(6)
Allergy-Hypersensitivity
(18)
Anaphylaxis
(1)
Angioedema
(9)
Antigen-Specific Immunity
(3)
Autoantibodies
(30)
Autoimmunity
(21)
Autoinflammatory
(3)
Biologicals
(6)
Blotting-LIA
(1)
Clinical-Immunology
(34)
Consensus Guidelines
(3)
CSF
(2)
Cytokines
(15)
Dermatomyositis
(2)
Diabetes
(4)
Drug Allergy
(7)
Drug Antibodies
(3)
ELISA
(9)
Erythropoietin
(1)
FceRI
(3)
Functional-Assays
(5)
GAD
(2)
Gardasil
(3)
Gastrointestinal
(2)
Genetic testing
(24)
HAE - Hereditary Angioedema
(4)
Haematological-Oncology
(4)
Hyper-IgE-Syndrome
(5)
Iatrogenic
(9)
Immunochemistry-Biochemical-Analytes
(2)
Immunodeficiency-Infection
(22)
Immunofluorescence
(7)
Immunomodulation
(6)
Inflammatory Disorders
(3)
Interferon
(4)
Laboratory-Immunology
(84)
LAMP
(6)
Neuroimmunology
(2)
Novel Immunoassays
(1)
Paraproteins
(2)
Pemphigus - Pemphigoid
(7)
Periodic Fever
(3)
Quality Assurance-Quality Control
(3)
Quorn
(1)
Scleroderma
(2)
Standardisation
(7)
TLR
(6)
Toll Like Receptor
(6)
Urticaria
(5)
Vaccination
(3)
WHIM
(3)
Showing posts with label Interferon. Show all posts
Showing posts with label Interferon. Show all posts
Thursday, January 31, 2013
IFNa assay, particularly on CSF (for Aicardi-Goutieres Syndrome) - From Matthew Cook
IFNa assay, particularly on CSF (for Aicardi-Goutieres Syndrome) - From Theo de Malmanche
Is anyone able to analyse CSF IFNa levels for our neonatologists?Thanks,
Theo
Thursday, November 15, 2012
Fwd: 23 month old with ?IFNgR Deficiency
---------- Forwarded message ----------
From: glenn reeves <glenn.reeves@gmail.com>
Date: Wed, Nov 14, 2012 at 8:28 PM
Subject: 23 month old with ?IFNgR Deficiency
To: ImmDefClin <glenn.reeves.lgidc@blogger.com>, ImmDefLab <glenn.reeves.lgidls@blogger.com>
Ben, post cam path, t-cell reconstitution may not necessarily be normal, so I would be careful implying that a total lymph count implies a normal cd4 count.
In addition, in adult non HIV non drug induced immune suppression NTMI relapses are common. This seems true in the Thai anti-ifn antibody PTs as well as the idiopathic disease largely in elderly women who haven't been shown as yet to have ifn-g pathway defects.
Dr Daman Langguth
MBChB FRACP, FRCPA
P:07 3377 8698
M:0414642282
F:07 3871 1877
From: glenn reeves <glenn.reeves@gmail.com>
Date: Wed, Nov 14, 2012 at 8:28 PM
Subject: 23 month old with ?IFNgR Deficiency
To: ImmDefClin <glenn.reeves.lgidc@blogger.com>, ImmDefLab <glenn.reeves.lgidls@blogger.com>
Ben, post cam path, t-cell reconstitution may not necessarily be normal, so I would be careful implying that a total lymph count implies a normal cd4 count.
In addition, in adult non HIV non drug induced immune suppression NTMI relapses are common. This seems true in the Thai anti-ifn antibody PTs as well as the idiopathic disease largely in elderly women who haven't been shown as yet to have ifn-g pathway defects.
Dr Daman Langguth
MBChB FRACP, FRCPA
P:07 3377 8698
M:0414642282
F:07 3871 1877
23 Month Old with ?IFNgR deficiency
Dear All,
>
> We've been consulted about a 23/12 old patient at the kids hospital in
> Perth who has developed disseminated non TB mycobacterium after Campath
> therapy for refractory Langerhan's Cell Histiocytosis (Histopath have
> assured us that the diagnosis is correct although there have been
> reports of LCH mimicing IFNgR deficiency which is known to respond to
> IFNg therapy).
>
> They've asked us about IFN g therapy as an option in this patient who
> has developed relapsed NTM involving the skin despite clarithromycin,
> rifabutin and ciprofloxacin. We are looking for a biomarker to prove IFN
> g pathway deficiency before embarking on this. Steve Holland from NIH
> has suggested doing CD119 (IFNgR1) on peripheral blood as an initial
> screen. We've found the Addenbroke's Hospital in the UK will examine the
> IL-12/IFNg/IFNgR pathway for us but we're wanting to know if anyone in
> Australia is doing this or has experience?
>
> Regards,
>
> Dr. Ben McGettigan
> Immunology Advanced Trainee
> Dept of Clinical Immunology
> Princess Margaret Hospital
> GPO Box D184 Perth WA 6840
> Ph
(08) 9340 - 8310
> Fax
(08) 9380 6246
>
> We've been consulted about a 23/12 old patient at the kids hospital in
> Perth who has developed disseminated non TB mycobacterium after Campath
> therapy for refractory Langerhan's Cell Histiocytosis (Histopath have
> assured us that the diagnosis is correct although there have been
> reports of LCH mimicing IFNgR deficiency which is known to respond to
> IFNg therapy).
>
> They've asked us about IFN g therapy as an option in this patient who
> has developed relapsed NTM involving the skin despite clarithromycin,
> rifabutin and ciprofloxacin. We are looking for a biomarker to prove IFN
> g pathway deficiency before embarking on this. Steve Holland from NIH
> has suggested doing CD119 (IFNgR1) on peripheral blood as an initial
> screen. We've found the Addenbroke's Hospital in the UK will examine the
> IL-12/IFNg/IFNgR pathway for us but we're wanting to know if anyone in
> Australia is doing this or has experience?
>
> Regards,
>
> Dr. Ben McGettigan
> Immunology Advanced Trainee
> Dept of Clinical Immunology
> Princess Margaret Hospital
> GPO Box D184 Perth WA 6840
> Ph
(08) 9340 - 8310> Fax
(08) 9380 6246
Subscribe to:
Posts (Atom)